Skip to content
Roopa Industries logo

Roopa Industries

530991 BSE
Price unavailable

Roopa Industries (ROOPAIND) share price was ₹42.60 at the 28 Oct 2026 close; market capitalisation ₹33.48 Cr; P/E (TTM) 266.25; sector Healthcare. The share price fell 20.4% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 5.0% year on year to ₹33.32 Cr and net profit was ₹0.33 Cr, against ₹0.28 Cr a year earlier (compared with Jun 2025). Promoters held 48.03% of Roopa Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 46/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹42.60 −11.10 −20.67% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹33.48 Cr
P/E (TTM)
266.25
EBITDA
₹8.30 Cr
Return on Equity
0.47%
Debt to Equity
1.72
Book Value
₹22.37
EPS (TTM)
₹0.16
52W High
₹63.40
52W Low
₹38.10

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,765.8035.034,23,675 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,609.0072.351,75,312 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,187.00108.051,18,166 Cr22.300.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.6034.671,11,730 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.8032.701,10,257 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Roopa Industries (this company)
—266.2533 Cr1.900.00%0.47%15.75%126 Cr0 Cr
Median 8 companies₹1,765.8053.691,18,001 Cr4.710.47%12.98%16.85%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

46 Average
Overall score

Data confidence 100/100

Category scores

Quality Strong 70
Returns, margins, earnings quality 22% weight
Valuation Poor 36
Cheap vs sector & own history 24% weight
Growth Weak 43
Sales & profit trajectory 9% weight
Financial Health Poor 23
Solvency, leverage, coverage 9% weight
Momentum Poor 24
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 48.4 to 62.8 days.

Technical Indicators

Oscillators

Bullish

Bearish
2
Neutral
4
Bullish
3

Overall

Bearish

Bearish
12
Neutral
4
Bullish
3

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
3.74% lower than 3Y

change over 1 year

Net Income Growth
-95% lower than 3Y

change over 1 year

Cash Flow Change
171%

change over 1 year

EBITDA Margin Change
24.57%

change over 1 year Operating margin 4.59% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
14.95
14.15
19.24
22.08
34.51
25.61
30.73
29.83
35.07
28.74
33.54
30.14
33.32
Expenses
13.92
12.45
18.36
21.15
33.46
23.97
29.76
29.39
33.67
27.11
31.5
27.07
31.79
Operating Profit
1.03
1.7
0.88
0.93
1.05
1.64
0.97
0.44
1.4
1.63
2.04
3.07
1.53
OPM %
6.89%
12.01%
4.57%
4.21%
3.04%
6.4%
3.16%
1.48%
3.99%
5.67%
6.08%
10.19%
4.59%
Other Income
0
0.02
0.4
0.71
0.24
0
0.92
1.14
0.02
0
0
-3.98
0.02
Interest
0.56
0.69
0.7
0.68
0.79
0.71
0.67
0.66
0.86
0.83
0.79
0.74
0.93
Depreciation
0.23
0.23
0.23
0.19
0.2
0.2
0.26
0.19
0.2
0.19
0.19
0.21
0.19
PBT
0.24
0.8
0.35
0.77
0.3
0.73
0.96
0.73
0.36
0.61
1.06
-1.86
0.43
Tax %
20.83%
25%
25.71%
38.96%
10%
19.18%
20.83%
43.84%
25%
24.59%
26.42%
-23.12%
23.26%
Net Profit
0.19
0.6
0.27
0.46
0.27
0.58
0.76
0.42
0.28
0.46
0.77
-1.43
0.33
EPS (₹)
0.24
0.76
0.34
0.58
0.34
0.74
0.97
0.53
0.36
0.58
0.98
-1.82
0.42
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
31
31
30
19
30
28
29
51
76
70
121
128
126
Expenses
29
31
28
22
28
26
26
48
72
66
117
119
117
Operating Profit
2
-1
2
-3
2
2
3
3
4
4
4
8
8
OPM %
7%
-2.8%
7%
-14%
8%
7%
10%
7%
5%
6%
3.4%
6%
7%
Other Income
0
3
0
5
0
1
0
0
1
1
2
-4
-4
Interest
1
1
2
1
1
1
1
1
2
3
3
3
3
Depreciation
1
1
1
1
1
1
1
1
1
1
1
1
1
PBT
0
0
0
0
1
1
1
1
2
2
3
0
0
Tax %
11%
35%
56%
-22%
24%
54%
24%
26%
25%
30%
25%
56%
—
Net Profit
0
0
0
1
1
0
1
1
1
2
2
0
0
EPS (₹)
0.2
0.22
0.24
0.69
0.76
0.47
0.92
1.3
1.72
1.93
2.58
0.1
0.16
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
8
8
8
8
8
8
8
8
8
8
Reserves
1
1
2
2
3
3
4
5
6
8
10
10
Borrowings
8
8
11
16
15
14
13
12
19
26
33
31
Other Liabilities
8
8
8
10
11
14
21
24
24
23
26
23
Total Liabilities
26
25
29
35
36
38
46
49
57
65
76
72
Fixed Assets
8
7
7
6
6
11
10
10
10
9
8
8
CWIP
0
0
0
2
4
0
0
1
1
1
1
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
18
18
22
27
26
28
36
39
46
55
68
64
Total Assets
26
25
29
35
36
38
46
49
57
65
76
72
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
1
-1
-5
4
2
-1
2
0
2
-7
5
Investing
0
0
0
2
-2
1
1
4
-1
1
2
0
Financing
0
-1
2
2
-2
-3
-1
-5
2
-2
5
-8
Net Cash Flow
0
0
0
0
0
0
0
1
0
1
0
-3
Free Cash Flow
0
1
-2
-7
2
2
-1
2
-2
2
-7
4
CFO/OP
28
-146
-50
168
184
157
-11
78
2
60
-143
59
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
66
99
146
233
134
157
147
112
34
43
39
63
Inventory Days
143
70
139
217
171
256
409
140
109
168
121
102
Days Payable
132
100
122
177
123
219
280
86
42
96
56
41
Cash Conversion Cycle
77
69
164
273
182
194
277
166
101
116
104
123
Working Capital Days
32
69
114
214
108
104
114
37
1
10
36
32
ROCE %
10%
10%
10%
6%
9%
9%
8%
10%
13%
12%
12%
15%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Roopa Industries insights

63 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

FIIs0.25%Promot.48.03%Others10.75%Public40.96%As ofSep 2026

Documents

Frequently Asked Questions about Roopa Industries

What does Roopa Industries Ltd do?
Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products[1]
Where is Roopa Industries Ltd (ROOPAIND) listed?
Roopa Industries Ltd trades under code 530991 on the BSE.
Which sector does Roopa Industries Ltd belong to?
Roopa Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Roopa Industries Ltd?
Roopa Industries Ltd has a market capitalisation of ₹33.48 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Roopa Industries Ltd?
Roopa Industries Ltd trades at a PE ratio of 266.25 as of 28 Oct 2026, on earnings per share of ₹0.16, against a book value of ₹22.37 per share.
What is the 52-week high and low of Roopa Industries Ltd?
Over the last 52 weeks Roopa Industries Ltd has traded between ₹38.1 and ₹63.4 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Roopa Industries Ltd?
Roopa Industries Ltd reported a return on equity of 0.47%. Its debt-to-equity ratio is 1.72.

Company Information

Incorporated in 1985, Roopa Industries Ltd is in the business of TPP and its allied products[1]

Website roopaindustries.com
Face Value ₹ 10
Shares Outstanding 78,58,770

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/530991.md for Roopa Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month